Last edition
News about Manufacturing
IIL to produce drug substance for Covaxin from June
Indian Immunologicals Ltd (IIL) has announced its plans to begin the production of drug substance meant for COVID-19 vaccine Covaxin from June 15, and despatch the first batch to Bharat Biotech by July
Manufacturing | 30/05/2021 | By Darshana | 199
Zydus introduces new tech enabled initiative to safeguard patients against counterfeit drugs
Zydus Cadila, an innovation-driven pharmaceutical company, announced that it has introduced a new IT enabled scratch code which shall be printed under a scratchable surface in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited
Manufacturing | 28/05/2021 | By Darshana | 490
Camfil, a global leader in air filtration equipment and clean air solutions, and Sinopharm GEPTECK announced the joint release of digital high-efficiency air supply units. Sinopharm is the largest pharmaceutical and healthcare group under the State-Owned Assets Supervision and Administration Commission of the State Council (SASAC) in China
Manufacturing | 26/05/2021 | By Darshana | 341
Cipla's RT-PCR test kit 'ViraGen' launched in India
Cipla Limited announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit 'ViraGen' for Covid-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd
Manufacturing | 20/05/2021 | By Darshana | 288
CureVac announced together with its collaboration partner GSK, first preclinical data in A Rat Model, Showing That Its Second-Generation Covid-19 vaccine candidate, CV2CoV, induces high levels of antigen production as well as strong and dose-dependent immune responses in vaccinated animals
Manufacturing | 15/05/2021 | By Darshana | 540
Glenmark Pharma introduces 400 mg version of FabiFlu for COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it will introduce a 400 mg version of oral antiviral FabiFlu, for the treatment of mild to moderate COVID-19 in India. The higher strength will improve patient compliance and experience, by effectively reducing the number of tablets that patients
Manufacturing | 06/08/2020 | By Darshana | 506
Lupin gets US FDA approval for generic Glyxambi tablets
Pharma major Lupin Limited has received tentative approval for its empagliflozin and linagliptin tablets, 10 mg/5 mg and 25 mg/5 mg, from the United States Food and Drug Administration (FDA) to market a generic version of Glyxambi tablets, 10 mg/5 mg and 25 mg/5 mg, of Boehringer Ingelheim Pharmaceuticals, Inc
Manufacturing | 24/07/2020 | By Darshana | 579
The 80-year old Indian Pharmaceutical Association (IPA), the national professional body of pharmacists engaged in various facets of the profession of pharmacy, will soon approach the national Trade Marks Registry (TMR) for the exclusive right of its acronym, IPA. A decision to approach the TMR, claiming absolute ownership of the acronym
Manufacturing | 22/07/2020 | By Darshana | 783
Patanjali launches ayurvedic medicine Coronil and Swasari to treat COVID-19
Baba Ramdev's Patanjali Yogapeeth based in Haridwar has launched ayurvedic medicine 'Coronil and Swasari', to treat the noval coronavirus infection (COVID-19), which the company said has been shown 100 per cent favourable results during clinical trials on affected patients
Manufacturing | 23/06/2020 | By Darshana | 422
FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study
Today, the U.S. Food and Drug Administration publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent performance validation study effort with the National Institutes of Health's (NIH) National Cancer Institute (NCI)
Manufacturing | 05/06/2020 | By Darshana | 334
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy